Navigation Links
Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call
Date:4/23/2008

BOTHELL, Wash., April 23 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will release its first quarter 2008 financial results on Wednesday, April 30, 2008 after the market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time to discuss the financial results for the first quarter and current business developments. The call will be hosted by John Hinson, president and chief executive officer, and Michael Matysik, senior vice president and chief financial officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

To access the conference call, please dial 800-257-3401. International participants can dial 303-262-2125. The call will also be webcast live at http://www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11113278#. An archived webcast will also be available at http://www.cardiacscience.com for 90 days.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Company Contact:

Mike Matysik

Cardiac Science Corporation

Sr. Vice President and CFO

(425) 402-2009

Investor Contact:

Doug Sherk

Jenifer Kirtland

EVC Group, Inc.

(415) 896-6820

Media Contact:

Christopher Gale

EVC Group, Inc.

(201) 646-5431

(203) 570-4681

cgale@evcgroup.com CSCX-F


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
2. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
3. Australia Chooses Cardiac Science to Equip Its Defence Force
4. Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
5. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
6. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
7. New research shows that iPods do not interfere with cardiac pacemakers
8. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
9. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading producer ... Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 ... form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... NY (PRWEB) , ... January 18, 2017 , ... Researchers from a new study ... do not fall low enough after prostate cancer treatment, this indicates there is still remaining ... risk of mortality. , “ The PSA test has always been an indicator of whether ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):